Published in Antimicrob Agents Chemother on October 01, 1983
Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. Antimicrob Agents Chemother (1993) 0.89
In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrob Agents Chemother (1981) 8.59
In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother (1982) 6.97
Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother (1977) 3.32
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother (1983) 2.70
Antibacterial activity of norfloxacin. Antimicrob Agents Chemother (1983) 2.15
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1980) 1.52
Clinical experience with prophylactic antibiotic bowel suppression in burn patients. Surgery (1978) 0.96
Historical development of intestinal antisepsis. World J Surg (1982) 0.88
Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J Pharm Sci (1977) 1.85
Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. Scand J Urol Nephrol Suppl (1995) 1.83
Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol (1988) 1.59
Rosamicin--a new drug for the treatment of bacterial prostatitis. Antimicrob Agents Chemother (1977) 1.37
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost (2009) 1.36
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up. Urology (1990) 1.32
Description and evaluation of a short-term reproduction test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem (2001) 1.30
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function. Antimicrob Agents Chemother (1987) 1.25
Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother (1977) 1.23
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials. J Urol (1970) 1.18
The importance of the pressure in the prostatic fossa and absorption of irrigating fluid during transurethral resection of the prostate. J Urol (1973) 1.16
3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol (1986) 1.15
Rosamicin in urethral and vaginal secretions and tissues in dogs and rats. Antimicrob Agents Chemother (1977) 1.15
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Antimicrob Agents Chemother (1980) 1.15
Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion. Scand J Infect Dis Suppl (1978) 1.14
Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother (1977) 1.11
Analysis of presenting symptoms in prostatism. J Urol (1984) 1.09
Oxolinic acid, a new chemotherapeutic agent in the treatment of urinary tract infection. J Urol (1971) 1.08
Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother (1983) 1.08
Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs. Invest Urol (1979) 1.07
[Postoperative nausea and vomiting]. Ugeskr Laeger (1997) 1.07
Influence of probenecid on serum levels and urinary excretion of cinoxacin. Antimicrob Agents Chemother (1979) 1.06
Scrotal herniation of the lower urinary tract. J Urol (1967) 1.05
Route and prophylaxis of ascending bladder infection in male patients with indwelling catheters. J Urol (1972) 1.03
Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics. Antimicrob Agents Chemother (1975) 1.01
Isolation and biological activity of aspidospermine and quebrachamine from an Aspidosperma tree source. J Pharm Biomed Anal (1994) 1.01
Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans. Antimicrob Agents Chemother (1973) 1.01
Treatment of urinary tract infections with cefotaxime: noncomparative and prospective comparative trials. Rev Infect Dis (1983) 1.00
Uroflowmetry. Urol Clin North Am (1996) 0.99
Some clinical aspects of uroflowmetry in elderly males. A population survey. Scand J Urol Nephrol (1986) 0.99
Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology (1976) 0.99
High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue. Antimicrob Agents Chemother (1986) 0.98
Intravenous administration of sodium colistimethate in urinary tract infections. Curr Ther Res Clin Exp (1967) 0.98
Uroflowmetry in asymptomatic elderly males. Br J Urol (1986) 0.97
Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am (1986) 0.97
Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections. Antimicrob Agents Chemother (1978) 0.97
Significance of prostatic weight in prostatism. Urol Int (1983) 0.96
Ambient solar UV radiation causes mortality in larvae of three species of Rana under controlled exposure conditions. Photochem Photobiol (2001) 0.93
Bacterial prostatitis: new methods of treatment. Urology (1991) 0.92
Experimental lipid A-induced nephritis in the dog. Invest Urol (1975) 0.92
Nager acrofacial dysostosis: early intervention and long-term planning. Cleft Palate J (1977) 0.92
Cefamandole and cefazolin in the therapy of complicated urinary tract infections. J Infect Dis (1978) 0.91
Posttraumatic priapism: successful treatment with autologous clot embolization. AJR Am J Roentgenol (1979) 0.90
Xenoendocrine disrupters-tiered screening and testing: filling key data gaps. Toxicology (2002) 0.90
Varicoid carcinoma of the esophagus. Radiology (1977) 0.90
The relevance of minimum urethral resistance in prostatism. J Urol (1983) 0.89
Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report. J Urol (1968) 0.89
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays. Antimicrob Agents Chemother (1981) 0.89
Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia. Urol Int (1995) 0.89
Urinary flow studies in normal kindergarten--and schoolchildren. Scand J Urol Nephrol (1983) 0.89
Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol (1989) 0.89
Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol (1981) 0.89
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids. Infection (1991) 0.89
Malignant interstitial cell testicular tumor. Cancer (1973) 0.89
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol (1987) 0.88
Effect of concurrent administration of aspirin and indomethacin on serum concentrations. Clin Pharmacol Ther (1974) 0.87
Prophylactic antibiotics in transurethral prostatectomy. J Urol (1981) 0.87
A comparative study of various electrodes in electromyography of the striated urethral and anal sphincter in children. Br J Urol (1985) 0.87
Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics. J Clin Pharmacol (1974) 0.87
A new anti-inflammatory derivative of imidazole which is less ulcerogenic than indomethacin in rats. Acta Pharmacol Toxicol (Copenh) (1979) 0.87
Stage- and species-specific developmental toxicity of all-trans retinoic acid in four native North American ranids and Xenopus laevis. Toxicol Sci (2000) 0.87
Determination of absorption of irrigating fluid during transurethral resection of the prostate by means of radioisotopes. J Urol (1969) 0.87
Value of postvoid residual urine determination in evaluation of prostatism. Urology (1982) 0.86
Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother (1984) 0.86
Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology (1995) 0.86
Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis. Urol Res (1977) 0.85
Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol (1983) 0.85
Spontaneous uroflowmetry in prostatism. Urology (1984) 0.85
Urethral condylomata, due to human papilloma virus (HPV) type 6/11., associated with transitional cell tumors in the bladder and ureter. A case report. Scand J Urol Nephrol Suppl (1995) 0.85
The significance of uninhibited detrusor contractions in prostatism. J Urol (1985) 0.84
Chronic bacterial prostatitis: theoretical and experimental considerations. Urol Res (1983) 0.83
Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 0.83
Investigating compensation and recovery of fathead minnow (Pimephales promelas) exposed to 17alpha-ethynylestradiol with metabolite profiling. Environ Sci Technol (2008) 0.83
Computed tomography of spondylolisthesis: patterns of associated pathology. J Comput Assist Tomogr (1985) 0.83
Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. Urol Clin North Am (1990) 0.83
Scanning electron microscopy of normal and malignant human urothelium. Urology (1976) 0.83
Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs. Infection (1979) 0.83
Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids. Antimicrob Agents Chemother (1987) 0.82
Infectious complications after instrumentation of urinary tract. Urology (1985) 0.82
Ceftazidime, a new cephalosporin in the treatment of complicated urinary tract infections: a comparative study with tobramycin. J Urol (1983) 0.82
Persistent bladder dysfunction after surgical and combination therapy of cancer of the cervix uteri stages Ib and IIa. Gynecol Oncol (1984) 0.82
Antibiotics excretion in canine vaginal and urethral secretions. Invest Urol (1978) 0.82
Pharmacokinetics of ampicillin and methoxymethyl ester of hetacillin in dogs. J Pharm Sci (1977) 0.82
Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries. Invest Radiol (1997) 0.82
Short-term cephalosporin prophylaxis in transurethral surgery. Clin Ther (1982) 0.81
Entomopathogenic fungi in flies associated with pastured cattle in Denmark. J Invertebr Pathol (2001) 0.81
NMR analysis of male fathead minnow urinary metabolites: a potential approach for studying impacts of chemical exposures. Aquat Toxicol (2007) 0.81
Prostatic fluid and tissue concentrations of ampicillin after administration of hetacillin ester (BL-P1761). Invest Urol (1976) 0.81